Home » 2017 » December

Cetya Therapeutics Announces Advanced Industries Award

  $170,000 Colorado Grant will advance Cetya’s novel targeted HDAC inhibitor program. Cetya Therapeutics, Inc. announces the award of a $170,000 Advanced Industries grant from the State of Colorado to support the development of its proprietary receptor ligand-targeted histone deacetylase

Learn More »